Skip to main content

Table 1 Baseline characteristics of patients with invasive Acinetobacter species infection

From: Molecular epidemiology of Acinetobacter baumannii complex causing invasive infections in Korean children during 2001–2020

 

No. of cases (%)

P

Total

AB

non-AB

N = 108

n = 60

n = 48

Sex, male

65 (60.2)

31 (51.7)

24 (50.0)

0.863

Median age (IQR), years

1.4 (0.1–7.9)

1.5 (0.1–6.8)

2.4 (0.4–11.3)

0.164

Underlying disease

    

 Malignancy

23 (21.3)

15 (25.0)

8 (16.7)

0.293

 Congenital heart disease

16 (14.8)

11 (18.3)

5 (10.4)

0.250

 Preterm, ELBWI

17 (15.7)

14 (23.3)

3 (6.3)

0.015

 Solid organ transplant

10 (9.3)

5 (8.3)

5 (10.4)

0.710

 Non-malignant chronic disease*

40 (37.0)

15 (25.0)

25 (52.1)

0.004

 None

2 (1.9)

0

2 (4.2)

-

Cultured specimen

    

 Blood

92 (85.2)

52 (86.7)

40 (83.3)

0.628

 Pleural fluid

3 (2.8)

3 (5.0)

0

-

 Ascites fluid

13 (12.0)

5 (8.3)

8 (16.7)

0.186

Location of admission

    

 Ward

37 (34.3)

8 (13.3)

30 (62.5)

< 0.001

 ICU

71 (65.7)

53 (88.3)

18 (37.5)

 

Duration of admission prior to infection, median days (IQR)

14.0 (2.5–49.0)

17.0 (6.0-43.5)

9.0 (1.0–51.0)

0.151

Mortality

    

 7-day mortality

26 (24.1)

24 (40.0)

2 (4.2)

< 0.001

 30-day mortality

32 (29.6)

28 (46.7)

4 (8.3)

< 0.001

  1. AB, Acinetobacter baumannii, ELBWI, extremely low birth weight infant; ICU, intensive care unit; IQR, interquartile range;
  2. * Chronic lung disease, n = 2; End stage renal disease, n = 11; Gastrointestinal disease, n = 13; Neurologic disease, n = 12; Post-CPR status, n = 2;